Knockdown of MTDH increases drug sensitivity to HDAC inhibitor and TRAIL combination treatment in endometrial cancer cellsProceedings in Obstetrics and Gynecology
AbstractUnderstanding the molecular mechanisms of chemoresistance is vital to design therapies to restore chemosensitivity. MTDH mediates drug resistance by regulating expression of genes required for the control of apoptosis and cell cycle. These findings indicate that sensitivity to chemotherapy agents and combination treatment with HDAC inhibitor and TRAIL can be restored by manipulating MTDH, and hence depletion of MTDH is a potentially novel avenue for effective cancer therapy.
- LBH 589,
Total Pages2 pages
RightsCopyright © Xiangbing Meng, Pavla Brachova, Shujie Yang, Zhi Xiong, Yuping Zhang, and Kimberly K. Leslie, 2011.
Creative Commons LicenseCreative Commons Attribution 3.0
Citation InformationXiangbing Meng, Pavla Brachova, Shujie Yang, Zhi Xiong, et al.. "Knockdown of MTDH increases drug sensitivity to HDAC inhibitor and TRAIL combination treatment in endometrial cancer cells" Vol. 2 Iss. 1 (2011) p. 1 - 2 ISSN: 2154-4751
Available at: http://works.bepress.com/xiangbing_meng/2/